ProQR Therapeutics N.V. (PRQR)
Data as of , from SEC Form 4 filings.
See up to 3 months of PRQR. The 7-day demo opens the 1M and 3M ranges and puts PRQR on your watchlist.
Start 7-day demoLatest PRQR insider trades
Boer Daniel Anton de - OfficerOpen-market purchase$354K- Bart Filius - DirectorOpen-market purchase$258K
- Boer Daniel Anton de - OfficerOpen-market purchase$261K
- Boer Daniel Anton de - OfficerOpen-market purchase$239K
- Bart Filius - DirectorOpen-market purchase$231K
Gylvin Lykke Hinsch - DirectorGrant or award14,595 sh- Gylvin Lykke Hinsch - DirectorGrant or award14,495 sh
About ProQR Therapeutics N.V. (PRQR)
ProQR Therapeutics N.V. files with the SEC under CIK 0001612940 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
PRQR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 350,000 | $612K |
PRQR insider transactions (Form 4)
77 Form 4 filings on record, the earliest from Jun 3, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Boer Daniel Anton de - Officer | Open-market purchase | Ordinary Shares | 200,000 | $1.77 | $354K | |
| Bart Filius - Director | Open-market purchase | Ordinary Shares | 150,000 | $1.72 | $258K | |
| Boer Daniel Anton de - Officer | Open-market purchase | Ordinary Shares | 150,000 | $1.74 | $261K | |
| Boer Daniel Anton de - Officer | Open-market purchase | Ordinary Shares | 150,000 | $1.59 | $239K | |
| Gylvin Lykke Hinsch - Director | Grant or award | Share Option (Right to Buy) | 14,595 | $0.00 | - | |
| Bart Filius - Director | Open-market purchase | Ordinary Shares | 150,000 | $1.54 | $231K | |
| Gylvin Lykke Hinsch - Director | Grant or award | Share Option (Right to Buy) | 14,495 | $0.00 | - |
PRQR insider trading FAQ
What is the latest insider trade for PRQR?
ProQR Therapeutics N.V. (PRQR) had 2 insider filings in the last 90 days, with the most recent on 2026-08-03. The full record for PRQR runs to 7 Form 4 filings, the earliest from 2026-06-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PRQR stock?
2 insider purchases of PRQR were filed in the last 90 days, totaling $612K.
How many insiders are selling PRQR stock?
No insider sales of PRQR were filed in the last 90 days.
Where can I see PRQR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PRQR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
7The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Boer Daniel Anton de view on EDGAR
- - Bart Filius view on EDGAR
- - Boer Daniel Anton de view on EDGAR
- - Boer Daniel Anton de view on EDGAR
- - Gylvin Lykke Hinsch view on EDGAR
- - Bart Filius view on EDGAR
- - Gylvin Lykke Hinsch view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where PRQR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PRQR with a 7-day demo
- PRQR on your watchlist
- Every PRQR Form 4 filing on record
- Up to 3 months of PRQR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive